We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSLR
2201
DELISTED
VIVINT SOLAR, INC.
VSLR
$133K 0.01%
+13,394
New +$96.3K
CEO
2202
DELISTED
CNOOC Limited
CEO
$133K 0.01%
1,175
+930
+380% +$105K
AR icon
2203
Antero Resources
AR
$11.6B
$132K 0.01%
+51,834
New +$136K
IPG
2204
DELISTED
Interpublic Group of Companies
IPG
$132K 0.01%
+7,665
New +$126K
VXRT
2205
DELISTED
Vaxart
VXRT
$132K 0.01%
+14,868
New +$42.7K
CTMX icon
2206
CytomX Therapeutics
CTMX
$752M
$131K 0.01%
+15,758
New +$146K
EVRI
2207
DELISTED
Everi Holdings
EVRI
$131K 0.01%
25,467
+13,171
+107% +$66.9K
FTSM icon
2208
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
$131K 0.01%
+2,178
New +$130K
NMR icon
2209
Nomura Holdings
NMR
$28.6B
$131K 0.01%
+29,613
New +$123K
IVAC
2210
DELISTED
Intevac Inc
IVAC
$131K 0.01%
23,904
+21,485
+888% +$112K
EVOP
2211
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$131K 0.01%
+5,725
New +$114K
VIVO
2212
DELISTED
Meridian Bioscience Inc
VIVO
$131K 0.01%
+5,626
New +$81.5K
KRA
2213
DELISTED
Kraton Corporation
KRA
$131K 0.01%
+7,594
New +$103K
OSB
2214
DELISTED
Norbord Inc.
OSB
$131K 0.01%
5,729
-14,617
-72% -$251K
BSM icon
2215
Black Stone Minerals
BSM
$3.02B
$130K 0.01%
20,061
+19,597
+4,223% +$125K
WAL icon
2216
Western Alliance Bancorporation
WAL
$8.89B
$130K 0.01%
+3,421
New +$120K
TGH
2217
DELISTED
Textainer Group Holdings limited
TGH
$130K 0.01%
+15,851
New +$130K
POLY
2218
DELISTED
Plantronics, Inc.
POLY
$130K 0.01%
8,864
+5,115
+136% +$66.7K
AT
2219
DELISTED
Atlantic Power Corporation
AT
$130K 0.01%
+65,102
New +$130K
CRVL icon
2220
CorVel
CRVL
$3.09B
$129K 0.01%
+5,475
New +$108K
RPV icon
2221
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
$129K 0.01%
2,698
+1,947
+259% +$88.7K
SRS icon
2222
ProShares UltraShort Real Estate
SRS
$16.5M
$129K 0.01%
+1,005
New +$151K
TRTX
2223
TPG RE Finance Trust
TRTX
$614M
$129K 0.01%
14,974
-23,561
-61% -$171K
UPLD icon
2224
Upland Software
UPLD
$14.2M
$129K 0.01%
+371
New +$116K
GNMK
2225
DELISTED
GenMark Diagnostics, Inc
GNMK
$129K 0.01%
8,779
+3,928
+81% +$39.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.